ST6GALNAC2 and COVID-19: The expression of the α-2,3 sialyltransferase ST3GAL4 and the O-glycan α-2,6 sialyltransferase ST6GALNAC2 were significantly elevated in the severe COVID-19 cohort (Fig. 3a).